Anteris Technologies Global Corp. has grown revenue −29% a year over three years and −29% a year over five. Revenue growth, 3-year annual rate: −29% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: −29%, growth has slowed since the five-year average. Years of annual history on file: 2, FY2024 to FY2025, as filed.

AVRAnteris Technologies Global Corp.

Healthcare

$6.63+52% 1Y

$6.63

$3.3852 weeks$10.57

Is it growing?

Watch

Growth is fading: revenue shrinking (−10% year on year) and operating margin narrowing (−2118.9 points).

2 to watch, 1 without data

Revenue trend−10% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−2118.9 points operating

Trailing-twelve-month operating margin, -5616.3% now against -3497.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is AVR growing?

Anteris Technologies Global Corp. has grown revenue −29% a year over three years and −29% a year over five.

−29%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −29%
Revenue growth, 5-year rate · −29% over three · growth has slowed since the five-year average
Years of annual history on file: 2
Years of annual history on file · FY2024 to FY2025, as filed

Details›